Fitbit’s stock rose 10% today following the announcement that it will collaborate with Dexom to develop and commercialize devices to help people better manage their diabetes.
Dexcom is a company that manufactures equipment that enables continuous glucose monitoring. In the early phases of the partnership, its data would be made available on the Ionic, which was Fitbit’s first smartwatch. Those who have the ailment would be able to monitor their exercise as well as their glucose levels immediately on their wrists thanks to this. Users of the Dexcom CGM will also have the advantage of being able to connect with millions of people through the social platform that Fitbit provides. According to James Park, CEO of Fitbit, “the power of our brand and our ability to track critical health metrics continuously for up to 4+ day 1, combined with Dexcom’s market leadership in CGM, presents a powerful combination that we hope will assist millions of people in better managing their diabetes.”
This cooperation is a beautiful illustration of how we plan to bring that vision to our users. Our goal with Ionic is to drive positive health outcomes and to create additional products that are focused on health, and this project is a great example of how we hope to do that.
This is a solution that will be available at the beginning of 2018 that may be thought of as a middle-of-the-road option for merging technology with diabetes management. Monitoring glucose levels in a way that does not require intrusive procedures is still held up as the pinnacle of diabetes care. Diabetes patients still don’t have any good alternatives to the traditional way of checking their glucose levels, which is to prick their finger.
Diabetes is a condition that lasts a person’s entire life and causes them to have an abnormally high quantity of sugar in their blood. It is one of the health hazards of our time that is developing at the highest rate, making it a serious matter relating to public health. More than 400 million people worldwide are impacted by this disease, making it the leading cause of blindness, renal failure, heart disease, stroke, and the amputation of lower limbs. Additionally, it is responsible for millions of fatalities each year.
Both of these businesses are committed to this endeavor for the foreseeable future. In the years to come, they want to keep looking for chances to collaborate in order to bring to market items that will assist people with diabetes in better managing their condition.